Administered via weekly subcutaneous injections, it regulates blood sugar by slowing gastric emptying, enhancing insulin release when blood glucose is elevated and reducing appetite through brain appetite center modulation for convenient long-term weight management
In patients with comorbid coronary artery disease, obesity, and diabetes, GLP-1 agonists and SGLT-2 inhibitors should be used as first-line agents, over metformin
It is vegan, non-GMO, and produced in a GMP-certified facility to support digestive health, gentle detox, and metabolic function
Sarbaziha, R., & Goldberg, D
A further consideration for women using tirzepatide (and potentially other incretin therapies) is the possible reduction in exposure to oral contraceptives, particularly around initiation and dose escalation
Jul 2019;186(1):24-36